Technovation Manila highlights science, innovation behind smoke-free progress

MANILA, Philippines — PMFTC Inc., the Philippine affiliate of Philip Morris International (PMI), brought together policy experts, scientists, health experts, and industry leaders on Nov. 10, 2026, for its “Technovation: Smoke-Free by PMFTC” summit at Manila Marriott Hotel in Pasay City.
The summit served as a platform for discussions on tobacco harm reduction, product innovation, consumer education, and evidence-based approaches that can support adult smokers who would otherwise smoke in their journey towards smoke-free alternatives.
In his welcome remarks, PMFTC President Zhenya Ivanov underscored the importance of bringing PMI’s flagship summit to the Philippines for the first time.
Article continues after this advertisement
READ: PMFTC strengthens collaboration with PNP in anti-illicit trade drive
FEATURED STORIES
NEWSINFO
NEWSINFO
NEWSINFO
“We have held conversations about science and innovation in different parts of the world. But bringing Technovation to Manila is special to us because the Philippines has an important role to play in our company’s transformation toward a smoke-free future. We want to share not just where we’re headed as a company, but also the science, technology, and thinking behind this journey,” Ivanov said.
His address was followed by a fireside chat between Vassilis Gkatzelis, PMI President for East & Southeast Asia, Pacific and Global Travel Retail, and lawyer and TV anchor Karen Jimeno. The conversation explored PMI’s smoke-free transformation, evolving consumer preferences, and the role of innovation in expanding access to smoke-free alternatives.
“What we have seen is that in countries where regulatory frameworks recognize that not all nicotine products are the same, we see a much faster transition to smoke-free alternatives,” Gkatzelis said.
“When you have the combination of access, information, right regulation, and proper enforcement, we see that cigarette smoking declines faster.”
Article continues after this advertisement
PMI leaders emphasized the continuous effort to correct misconceptions about nicotine and smoking-related harm. Experts at the summit stressed that although nicotine is addictive and not risk-free, it is combustion, or the burning of tobacco that produces many of the harmful chemicals associated with smoking-related diseases.
They added that science-based information can help adult smokers understand the differences between combustible cigarettes and non-combustible alternatives, while underscoring the need for appropriate regulation and safeguards.
Article continues after this advertisement
Speaking on the evolution of innovation in the industry, PMI Vice President Communications and Engagement Tommaso Di Giovanni emphasized that innovation should make a positive difference in people’s lives, and that meaningful progress begins with finding better solutions to existing challenges, even when new technologies initially face skepticism.
“The true measure of innovation is the positive difference it can make in people’s lives, not how advanced a technology is. At its best, innovation gives us the power to tackle complex challenges and turn scientific progress into progress for society,” he said.
Scientific and public health perspectives took center stage during a panel featuring University of Louisville Professor Emeritus Brad Rodu, public health expert Dr. Sharifa Ezat Wan Puteh, psychiatrist Dr. Tomohiro Shirasaka, and urologist Dr. Rogelio Varela Jr. Moderated by PMI Head of Scientific Engagement for East Asia and Australia Yvonne Khoo, the discussion examined how scientific research, product innovation, and evidence-based regulation can help reduce the harm caused by cigarette smoking.
Innovation remained a recurring theme throughout the summit. Swedish trendspotter Magnus Lindkvist shared insights on disruptive innovation and how emerging technologies are reshaping industries and consumer behavior.
PMFTC Senior Director for Smoke-Free Products Vickna Tharmalingam showcased PMI’s multicategory smoke-free portfolio, including the induction-heated IQOS ILUMA i and ZYN nicotine pouches.
The conversation then turned to policy and regulation through the “Voices of Change” panel, which brought together Martin Cullip of Taxpayers Protection Alliance’s Consumer Center, Rachmadin Ismail of Indonesian news outfit Tirto.id, and PMFTC Director for Regulatory and Scientific Affairs Atty. Marco Santiago.
The panel, moderated by PMFTC Communications Director Atty. John Peter Ferdinand Echiverri, drew on international experience to explore regulatory approaches, consumer access, and the role of tobacco harm reduction in accelerating the shift away from cigarettes.
In her closing remarks, PMFTC Senior Director for Corporate Affairs Atty. Chita Herce emphasized the importance of collaboration among government, industry, and other stakeholders in advancing a smoke-free future. She underscored the need to translate scientific innovation into meaningful progress through informed dialogue, evidence-based policies, and responsible regulation.
READ: PHILTHRA: Studies back lower-risk nicotine products
“Science can open new possibilities. But we turn innovation into progress only when we work together,” Herce said.
“If today’s conversations have helped us better understand the science, consider new perspectives, or ask more informed questions, then I believe we’ve made a worthwhile start.”
PMI has invested more than USD 16 billion globally in smoke-free research and development since 2008. The company said 99 percent of its adjusted R&D expenditure is now directed toward its smoke-free business, supported by more than 1,600 specialized R&D positions.
Your subscription could not be saved. Please try again.
Your subscription has been successful.
As of the third quarter of 2026, smoke-free net revenues accounted for over 40 percent of PMI’s total net revenues. Smoke-free products are now available in 110 markets and are used by more than 43 million adults worldwide. /atm
KioskNews shows a cleaned-up reading view extracted from the publisher’s page — the original always lives on their site, not ours.